COPI coatomer complex proteins facilitate the translocation of anthrax lethal factor across vesicular membranes in vitro
- Section of Molecular Medicine, Department of Medicine, Boston University School of Medicine, Boston, MA 02118
-
Edited by John J. Mekalanos, Harvard Medical School, Boston, MA, and approved February 7, 2008 (received for review October 24, 2007)
Abstract
The delivery of the diphtheria toxin catalytic domain (DTA) from acidified endosomes into the cytoplasm of eukaryotic cells requires protein–protein interactions between the toxin and a cytosolic translocation factor (CTF) complex. A conserved peptide motif, T1, within the DT transmembrane helix 1 mediates these interactions. Because the T1 motif is also present in the N-terminal segments of lethal factor (LF) and edema factor (EF) in anthrax toxin, we asked whether LF entry into the cell might also be facilitated by target cell cytosolic proteins. In this study, we have used LFnDTA and its associated ADP-ribosyltransferase activity (DTA) to determine the requirements for LF translocation from the lumen of endosomal vesicles to the external medium in vitro. Although low-level release of LFnDTA from enriched endosomal vesicles occurs in the absence of added factors, translocation was enhanced by the addition of cytosolic proteins and ATP to the reaction mixture. We show by GST-LFn pull-down assays that LFn specifically interacts with at least ζ-COP and β-COP of the COPI coatomer complex. Immunodepletion of COPI coatomer complex and associated proteins from cytosolic extracts blocks in vitro LFnDTA translocation. Translocation may be reconstituted by the addition of partially purified bovine COPI to the translocation assay mixture. Taken together, these data suggest that the delivery of LF to the cytosol requires either COPI coatomer complex or a COPI subcomplex for translocation from the endosomal lumen. This facilitated delivery appears to use a mechanism that is analogous to that of DT entry.
Footnotes
- *To whom correspondence should be addressed at: Section of Molecular Medicine, Department of Medicine, Boston University School of Medicine, Evans Biomedical Research Center, Room 830, 650 Albany Street, Boston, MA 02118. E-mail: jrmrphy{at}bu.edu
-
Author contributions: A.G.T., A.B., C.T., R.H., and J.R.M. designed research; A.G.T., A.B., C.T., and R.H. performed research; A.G.T., A.B., C.T., R.H., and J.R.M. analyzed data; and A.G.T., A.B., C.T., R.H., and J.R.M. wrote the paper.
-
The authors declare no conflict of interest.
-
This article is a PNAS Direct Submission.
-
This article contains supporting information online at www.pnas.org/cgi/content/full/0710100105/DCSupplemental.
-
Freely available online through the PNAS open access option.
- © 2008 by The National Academy of Sciences of the USA





